E-LIB Suche - Ergebnisse für: Shirai, Fumiyuki

1

Structure-based development of novel substrate-type G9a inh..:

Nishigaya, Yosuke ; Takase, Shohei ; Sumiya, Tatsunobu...
Bioorganic & Medicinal Chemistry Letters. , 2024

Link: https://doi.org/10.1016/..

2

BET protein–dependent E2F pathway activity confers bell-sha..:

Morino, Shun ; Mashima, Tetsuo ; Shirai, Fumiyuki...
Cancer Letters. 584 (2024) - p. 216632 , 2024

Link: https://doi.org/10.1016/..

3

An ex vivo screening using mouse brain mitochondria identif..:

Kubota-Sakashita, Mie ; Kawakami, Hirochika ; Kikuzato, Ko...
Biochemical and Biophysical Research Communications. 691 (2024) - p. 149253 , 2024

Link: https://doi.org/10.1016/..

4

Reduction of H3K9 methylation by G9a inhibitors improves th..:

Matoba, Shogo ; Shikata, Daiki ; Shirai, Fumiyuki...
Stem Cell Reports. , 2024

Link: https://doi.org/10.1016/..

5

APC/PIK3CA mutations and β-catenin status predict tankyrase..:

Chen, Mingjue ; Mashima, Tetsuo ; Oishi, Taichi...
British Journal of Cancer. 130 (2023) 1 - p. 151-162 , 2023

Link: https://doi.org/10.1038/..

6

A specific G9a inhibitor unveils BGLT3 lncRNA as a universa..:

Takase, Shohei ; Hiroyama, Takashi ; Shirai, Fumiyuki...
Nature Communications. 14 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

7

Discovery of Novel Substrate-Competitive Lysine Methyltrans..:

Nishigaya, Yosuke ; Takase, Shohei ; Sumiya, Tatsunobu...
Journal of Medicinal Chemistry. 66 (2023) 6 - p. 4059-4085 , 2023

Link: https://doi.org/10.1021/..

8

Novel tankyrase inhibitors suppress TDP-43 aggregate format..:

Tanji, Kunikazu ; Mori, Fumiaki ; Shirai, Fumiyuki...
Biochemical and Biophysical Research Communications. 537 (2021) - p. 85-92 , 2021

Link: https://doi.org/10.1016/..

9

Design and Discovery of an Orally Efficacious Spiroindolino..:

Shirai, Fumiyuki ; Mizutani, Anna ; Yashiroda, Yoko...
Journal of Medicinal Chemistry. 63 (2020) 8 - p. 4183-4204 , 2020

Link: https://doi.org/10.1021/..

10

Discovery of Novel Spiroindoline Derivatives as Selective T..:

Shirai, Fumiyuki ; Tsumura, Takeshi ; Yashiroda, Yoko...
Journal of Medicinal Chemistry. 62 (2019) 7 - p. 3407-3427 , 2019

Link: https://doi.org/10.1021/..

11

RK‐287107, a potent and specific tankyrase inhibitor, block..:

Mizutani, Anna ; Yashiroda, Yoko ; Muramatsu, Yukiko...
Cancer Science. 109 (2018) 12 - p. 4003-4014 , 2018

Link: https://doi.org/10.1111/..

12

Identification of pyrrolo[2,3- d ]pyrimidines as potent HCK..:

Koda, Yasuko ; Kikuzato, Ko ; Mikuni, Junko...
Bioorganic & Medicinal Chemistry Letters. 27 (2017) 22 - p. 4994-4998 , 2017

Link: https://doi.org/10.1016/..

13

Activity cliff for 7-substituted pyrrolo-pyrimidine inhibit..:

Yuki, Hitomi ; Kikuzato, Ko ; Koda, Yasuko...
Bioorganic & Medicinal Chemistry. 25 (2017) 16 - p. 4259-4264 , 2017

Link: https://doi.org/10.1016/..

14

Optimization of 2,4-diamino-5-fluoropyrimidine derivatives ..:

Kunikawa, Shigeki ; Tanaka, Akira ; Mukoyoshi, Koichiro...
Bioorganic & Medicinal Chemistry. 23 (2015) 13 - p. 3269-3277 , 2015

Link: https://doi.org/10.1016/..

15

Effects of non-steroidal anti-inflammatory drugs on Aβ depo..:

Morita, Masahiko ; Osoda, Kazuhiko ; Yamazaki, Mayako...
Brain Research. 1295 (2009) - p. 186-191 , 2009

Link: https://doi.org/10.1016/..